Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Cal/OSHA Stresses Importance Of Taking Precautions To Prevent Heat Illnesses
With triple digit temperatures expected over the weekend and into early next week, Cal/OSHA urges employers to observe the precautions specified in the heat illness prevention regulation. To ensure compliance Cal/OSHA will have teams of investigators inspecting outdoor employers over the weekend for heat illness prevention requirements. For employees working outdoors, the hot sun with high temperatures can be life-threatening.
generic viagra online
Medizone Announces That Its AsepticSure(TM) Development Program Is Reaching Objectives On Two Fronts
Early results from the second series of trials have demonstrated a 5 log reduction (99.999%) in Pseudomonas aeruginousa and a 4.4 log reduction (99.994%) in Methicillin Resistant Staph Aureus (MRSA). Both of these pathogens are of major concern to medical treatment facilities world wide with the spread of MRSA infection often being referred to as the "silent epidemic". The CDC reported (JAMA 2007) that MRSA alone is now associated with an estimated 19,000 deaths annually in the US. Dr. Michael E. Shannon, Medizone"s Director of Medical Affairs commented, "Although the results from our first round of trials were very encouraging, introducing several procedural refinements in this second round resulted in levels of bactericidal action well above what was expected. Indeed, breaking through the 5 log barrier has led us to conclude that with a third technological development still to be introduced in this series of trials, the bactericidal ceiling for our system is now unclear, but well above what we ever expected. Needless to say, we are very excited over these findings and even more convinced that our new technologies will save hundreds of thousands of lives each year world wide. Add to the system"s efficacy the fact that it will be safe, extremely cost effective and adaptable to virtually any situation anywhere, leads me to conclude that AsepticSure will have a global reach."
News of the day
Journal Of Alzheimer's Disease Annual Award For Outstanding Contribution Awarded To John P. Cogswell, Ph.D.
John P. Cogswell, PhD, has been chosen as the recipient of the 2009 Alzheimer Award presented by the Journal of Alzheimer"s Disease in recognition of his outstanding work, "Identification of miRNA changes in Alzheimer"s disease brain and CSF yields putative biomarkers and insights into disease pathways" (J Alzheimers Dis 14: 27-41, 2008) by J.P. Cogswell et al.
Endocrinology

UK Court Of Appeal Rules In Smith & Nephew's Favour

Smith & Nephew"s Advanced Wound Management division (NYSE:SNN) announced that the UK Court of Appeal has ruled as invalid all claims asserted against Smith and Nephew of the patent EP 0 626 720 that is licensed to Kinetic Concepts, Inc. (NYSE: KCI). As a result, the preliminary injunction against Smith & Nephew"s RENASYS(TM)-F NPWT system has been lifted. The Patents Court had ruled on 1 May, 2009 that 7 out of 10 claims asserted were invalid but that the remaining 3 had been infringed by Smith & Nephews RENASYS-F dressing. This decision was appealed and subsequently won by Smith & Nephew with today"s Court ruling. "This favourable ruling for Smith & Nephew clears a major legal hurdle in the UK allowing us to offer our customers the breadth of NPWT products with proven clinical efficacy," said Robin Carlstein, Senior Vice President of Advanced Wound Devices at Smith & Nephew. "Clearly, we are pleased with the UK Court of Appeal"s findings in this matter and look forward to servicing our customers with our RENASYS(TM)-F NPWT products in a very important market for the company." Smith & Nephew


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009